Literature DB >> 26082557

MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction.

Yanfei Yang1, Hui-Wen Cheng1, Yiling Qiu1, David Dupee1, Madyson Noonan1, Yi-Dong Lin1, Sudeshna Fisch1, Kazumasa Unno1, Konstantina-Ioanna Sereti1, Ronglih Liao2.   

Abstract

RATIONALE: In response to injury, the rodent heart is capable of virtually full regeneration via cardiomyocyte proliferation early in life. This regenerative capacity, however, is diminished as early as 1 week postnatal and remains lost in adulthood. The mechanisms that dictate postinjury cardiomyocyte proliferation early in life remain unclear.
OBJECTIVE: To delineate the role of miR-34a, a regulator of age-associated physiology, in regulating cardiac regeneration secondary to myocardial infarction (MI) in neonatal and adult mouse hearts. METHODS AND
RESULTS: Cardiac injury was induced in neonatal and adult hearts through experimental MI via coronary ligation. Adult hearts demonstrated overt cardiac structural and functional remodeling, whereas neonatal hearts maintained full regenerative capacity and cardiomyocyte proliferation and recovered to normal levels within 1-week time. As early as 1 week postnatal, miR-34a expression was found to have increased and was maintained at high levels throughout the lifespan. Intriguingly, 7 days after MI, miR-34a levels further increased in the adult but not neonatal hearts. Delivery of a miR-34a mimic to neonatal hearts prohibited both cardiomyocyte proliferation and subsequent cardiac recovery post MI. Conversely, locked nucleic acid-based anti-miR-34a treatment diminished post-MI miR-34a upregulation in adult hearts and significantly improved post-MI remodeling. In isolated cardiomyocytes, we found that miR-34a directly regulated cell cycle activity and death via modulation of its targets, including Bcl2, Cyclin D1, and Sirt1.
CONCLUSIONS: miR-34a is a critical regulator of cardiac repair and regeneration post MI in neonatal hearts. Modulation of miR-34a may be harnessed for cardiac repair in adult myocardium.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cellular proliferation; miR-34a, mouse; myocardial infarction; myocytes, cardiac; regeneration

Mesh:

Substances:

Year:  2015        PMID: 26082557      PMCID: PMC4769861          DOI: 10.1161/CIRCRESAHA.117.305962

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  41 in total

Review 1.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 2.  The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.

Authors:  Bin Zhao; Karen Tumaneng; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2011-08-01       Impact factor: 28.824

3.  Transient regenerative potential of the neonatal mouse heart.

Authors:  Enzo R Porrello; Ahmed I Mahmoud; Emma Simpson; Joseph A Hill; James A Richardson; Eric N Olson; Hesham A Sadek
Journal:  Science       Date:  2011-02-25       Impact factor: 47.728

4.  Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice.

Authors:  Michael Bauer; Susan Cheng; Mohit Jain; Soeun Ngoy; Catherine Theodoropoulos; Anna Trujillo; Fen-Chiung Lin; Ronglih Liao
Journal:  Circ Res       Date:  2011-03-03       Impact factor: 17.367

5.  Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size.

Authors:  Mei Xin; Yuri Kim; Lillian B Sutherland; Xiaoxia Qi; John McAnally; Robert J Schwartz; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Sci Signal       Date:  2011-10-25       Impact factor: 8.192

6.  MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes.

Authors:  Enzo R Porrello; Brett A Johnson; Arin B Aurora; Emma Simpson; Young-Jae Nam; Scot J Matkovich; Gerald W Dorn; Eva van Rooij; Eric N Olson
Journal:  Circ Res       Date:  2011-07-21       Impact factor: 17.367

7.  Surgical models for cardiac regeneration in neonatal mice.

Authors:  Ahmed I Mahmoud; Enzo R Porrello; Wataru Kimura; Eric N Olson; Hesham A Sadek
Journal:  Nat Protoc       Date:  2014-01-16       Impact factor: 13.491

8.  c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart.

Authors:  Sophy A Jesty; Michele A Steffey; Frank K Lee; Martin Breitbach; Michael Hesse; Shaun Reining; Jane C Lee; Robert M Doran; Alexander Yu Nikitin; Bernd K Fleischmann; Michael I Kotlikoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

9.  Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation.

Authors:  Chris Jopling; Eduard Sleep; Marina Raya; Mercè Martí; Angel Raya; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

10.  miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.

Authors:  Nora Bandi; Erik Vassella
Journal:  Mol Cancer       Date:  2011-05-16       Impact factor: 27.401

View more
  89 in total

1.  Neonatal Heart Regeneration: Comprehensive Literature Review.

Authors:  Nicholas T Lam; Hesham A Sadek
Journal:  Circulation       Date:  2018-07-24       Impact factor: 29.690

2.  Circular RNA circDENND2A protects H9c2 cells from oxygen glucose deprivation-induced apoptosis through sponging microRNA-34a.

Authors:  Yuanxia Shao; Peng Zhong; Li Sheng; Hongjian Zheng
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

3.  Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.

Authors:  Bianca C Bernardo; Jenny Y Y Ooi; Aya Matsumoto; Yow Keat Tham; Saloni Singla; Helen Kiriazis; Natalie L Patterson; Junichi Sadoshima; Susanna Obad; Ruby C Y Lin; Julie R McMullen
Journal:  J Physiol       Date:  2016-07-20       Impact factor: 5.182

Review 4.  MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes.

Authors:  Hassan Dehaini; Hussein Awada; Ahmed El-Yazbi; Fouad A Zouein; Khodr Issa; Assaad A Eid; Maryam Ibrahim; Adnan Badran; Elias Baydoun; Gianfranco Pintus; Ali H Eid
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

Review 5.  Emergence of miR-34a in radiation therapy.

Authors:  Jerome Lacombe; Frederic Zenhausern
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-01       Impact factor: 6.312

Review 6.  The emerging therapeutic role of mesenchymal stem cells in anthracycline-induced cardiotoxicity.

Authors:  Huanrong Lan; Qi Xue; Yuyao Liu; Ketao Jin; Xingliang Fang; Hong Shao
Journal:  Cell Tissue Res       Date:  2021-01-12       Impact factor: 5.249

Review 7.  The emergence of noncoding RNAs as Heracles in autophagy.

Authors:  Jian Zhang; Peiyuan Wang; Lin Wan; Shouping Xu; Da Pang
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

Review 8.  Understanding cardiomyocyte proliferation: an insight into cell cycle activity.

Authors:  Murugavel Ponnusamy; Pei-Feng Li; Kun Wang
Journal:  Cell Mol Life Sci       Date:  2016-09-30       Impact factor: 9.261

Review 9.  Developing miRNA therapeutics for cardiac repair in ischemic heart disease.

Authors:  Kai Zhu; Dingqian Liu; Hao Lai; Jun Li; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

10.  Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.

Authors:  Parul Mehra; Yiru Guo; Yibing Nong; Pawel Lorkiewicz; Marjan Nasr; Qianhong Li; Senthilkumar Muthusamy; James A Bradley; Aruni Bhatnagar; Marcin Wysoczynski; Roberto Bolli; Bradford G Hill
Journal:  Basic Res Cardiol       Date:  2018-10-23       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.